Dual eligibles with mental disorders and medicare Part D: How are they faring?

Health Affairs

Volumn 28, Issue 3, 2009, Pages 746-759

  Donohue, Julie M ^a   Huskamp, Haiden A ^b   Zuvekas, Samuel H ^c  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABILIFY DISCMELT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; CARBAMAZEPINE; CITALOPRAM; DEPAKOTE ER; DULOXETINE; ESCITALOPRAM; LAMOTRIGINE; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PSYCHOTROPIC AGENT; RISPERIDONE; UNCLASSIFIED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID;

ARTICLE; BIPOLAR DISORDER; DRUG COST; FINANCIAL MANAGEMENT; HUMAN; MAJOR DEPRESSION; MEDICAID; MEDICARE; MENTAL DISEASE; RISK MANAGEMENT; SCHIZOPHRENIA;

AGED; DRUG COSTS; DRUG UTILIZATION REVIEW; ELIGIBILITY DETERMINATION; FINANCING, GOVERNMENT; FINANCING, PERSONAL; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; INSURANCE COVERAGE; INSURANCE, PHARMACEUTICAL SERVICES; MEDICAID; MEDICARE; MENTAL DISORDERS; PSYCHOTROPIC DRUGS; TREATMENT OUTCOME; UNITED STATES;

EID: 66749127374     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.28.3.746     Document Type: Article

References (44)

1. Centers for Medicare and Medicaid Services, "Medicare Prescription Drug Benefit's Projected Costs Continue to Drop," Press Release, 31 January 2008, http://www.cms.hhs.gov/apps/media/press-releases.asp (accessed 4 March 2009).
2. J. Donohue, "Mental Health in the Medicare Part D Drug Benefit: A New Regulatory Model?" Health Affairs 25, no. 3 (2006): 707-719.
3. N.E. Morden and L.P. Garrison Jr., "Implications of Part D for Mentally Ill Dual Eligibles: A Challenge for Medicare," Health Affairs 25, no. 2 (2006): 491-500.
4. CMS, "Medicare Releases Part D Data for 2006 and 2007 at Medicare Prescription Drug Benefit Symposium," 30 October 2008, http://www.cms.hhs. gov/PrescriptionDrugCovGenIn/Downloads/PartDSymposiumFactSheet-2008.pdf (accessed 4 March 2009).
5. D.C. Grabowski, "Special Needs Plans and the Coordination of Benefits and Services for Dual Eligibles," Health Affairs 28, no. 1 (2009): 136-146.
6. For example, see F.C. Murphy et al., "Decision-Making Cognition in Mania and Depression," Psychological Medicine 31, no. 4 (2001): 679-693. (Pubitemid 32421969)
7. J. Hoadley, E. Hargrave, and J. Cubanski, "Medicare Part D 2008 Data Spotlight: Low-Income Subsidy Plan Availability," April 2008, http://www.kff.org/medicare/7763.cfm (accessed 23 March 2009).
8. Authors' calculation based on data from ibid.
9. Hoadley et al., "Medicare Part D 2008 Data Spotlight."
10. Kaiser Family Foundation, "The Medicare Prescription Drug Benefit Fact Sheet - An Updated Fact Sheet," February 2008, http://www.kff.org/ medicare/7044.cfm (accessed 23 March 2009).
11. M.V. Pauly and Y. Zeng. "Adverse Selection and the Challenges to Stand-Alone Prescription Drug Insurance," Frontiers in Health Policy Research 7 (2004): 55-74.
12. J. Robst, J.M. Levy, and M.J. Ingber, "Diagnosis-Based Risk Adjustment for Medicare Prescription Drug Plan Payments," Health Care Financing Review 28, no. 4 (2007): 15-30. (Pubitemid 47173624)
13. J. Robst, J.M. Levy, and M.J. Ingber, "Diagnosis-Based Risk Adjustment for Medicare Prescription Drug Plan Payments," Health Care Financing Review 28, no. 4 (2007): 15-30. Ibid.
14. J. Hsu et al., "Distributing $800 Billion: An Early Assessment of Medicare Part D Risk Adjustment," Health Affairs 28, no. 1 (2009): 215-225.
15. Full-benefit dual eligibles pay $1.10-$2.40 for generic and $3.20-$6.00 for brand-name drugs in 2009.
16. U.S. Department of Health and Human Services, "Medicare Program: Medicare Advantage and Prescription Drug Program MIPPA Drug Formulary and Protected Classes Policies," Federal Register 74, no. 11 (16 January 2009): 2881-2888.
17. Hoadley et al., "Medicare Part D 2008 Data Spotlight."
18. Avalere Health, "Low-Income Medicare Beneficiaries Will Have Fewer Part D Options in 2009," 7 October 2008, http://www.avalerehealth.net/wm/ show.php?c=1&id=791 (accessed 4 March 2009).
19. "Low-Income Medicare Beneficiaries Will Have Fewer Part D Options in 2009," 2008, http://www.avalerehealth.net/wm/show.php?c=1&id=791 Ibid.
20. Hoadley et al., "Medicare Part D 2008 Data Spotlight."
21. Beginning in 2009, the CMS weights premiums not by total Medicare but by LIS beneficiary enrollment to minimize the number of beneficiaries subject to plan reassignment.
22. J. Hoadley et al., "Medicare Prescription Drug Plans in 2008 and Key Changes since 2006," April 2008, http://www.kff.org/medicare/upload/7762. pdf (accessed 23 March 2009).
23. J.M. Polinski, P.S. Wang, and M.A. Fischer, "Medicaid's Prior Authorization Program and Access to Atypical Antipsychotic Medications," Health Affairs 26, no. 3 (2007): 750-760.
24. S.B. Soumerai et al., "Use of Atypical Antipsychotic Drugs for Schizophrenia in Maine Medicaid following a Policy Change," Health Affairs 27, no. 3 (2008): w185-w195 (published online 1 April 2008; 10.1377/hlthaff.27. 3.w185).
25. H.A. Huskamp, "Managing Psychotropic Drug Costs: Will Formularies Work?" Health Affairs 22, no. 5 (2003): 84-96. (Pubitemid 41388724)
26. M.J. Arranz and S. Kapur, "Pharmacogenetics in Psychiatry: Are We Ready for Widespread Clinical Use?" Schizophrenia Bulletin 34, no. 6 (2008): 1130-1144.
27. CMS, Medicare Prescription Drug Benefit Manual, 18 July 2008, chap. 6, http://www.cms.hhs.gov/PrescriptionDrugCovContra/Downloads/R2PDB.pdf (accessed 5 March 2009).
28. J.S. Crowley, D. Ashner, and L. Elam, State Medicaid Outpatient Prescription Drug Policies: Findings from a National Survey, 2005 Update, October 2005, http://www.kff.org/medicaid/7381.cfm (accessed 23 March 2009).
29. J.S. Crowley, D. Ashner, and L. Elam, State Medicaid Outpatient Prescription Drug Policies: Findings from a National Survey, 2005 Update, 2005, http://www.kff.org/medicaid/7381.cfm. Ibid.
30. W.H. Shrank et al., "The Effect of Transitioning to Medicare Part D Drug Coverage in Seniors Dually Eligible for Medicare and Medicaid," Journal of the American Geriatrics Society 56, no. 12 (2008): 2304-2310.
31. J.P. Hall, N.K. Kurth, and J.M. Moore, "Transition to Medicare Part D: An Early Snapshot of Barriers Experienced by Younger Dual Eligibles with Disabilities," American Journal of Managed Care 13, no. 1 (2007): 14-18. (Pubitemid 46180506)
32. J.C. West et al., "Medication Access and Continuity: The Experiences of Dual-Eligible Psychiatric Patients during the First Four Months of the Medicare Prescription Drug Benefit," American Journal of Psychiatry 164, no. 5 (2007): 789-796. (Pubitemid 46808534)
33. J.C. West et al., "Medicare Prescription Drug Benefits: Medication Access and Continuity among Dual Eligible Psychiatric Patients," Journal of Clinical Psychiatry (forthcoming).
34. J.M. Donohue and R.G. Frank, "Estimating Medicare Part D's Impact on Medication Access among Dually Eligible Beneficiaries with Mental Disorders," Psychiatric Services 58, no. 10 (2007): 1285-1291. (Pubitemid 350043578)
35. D. Robinson et al., "Predictors of Relapse following Response from a First Episode of Schizophrenia or Schizoaffective Disorder," Archives of General Psychiatry 56, no. 3 (1999): 241-247;
36. and S.B. Soumerai et al., "Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing Homes," New England Journal of Medicine 325, no. 15 (1991): 1072-1077.
37. P. Neuman et al., "Medicare Prescription Drug Benefit Progress Report: Findings from a 2006 National Survey of Seniors," Health Affairs 26, no. 5 (2007): w630-w643 (published online 21 August 2007; 10.1377/hlthaff.26.5.w630).
38. Hoadley et al., "Medicare Part D 2008 Data Spotlight."
39. Hoadley et al., "The Role of Beneficiary-Centered Assignment for Medicare Part D," June 2007, http://www.medpac.gov/documents/June07-Bene- centered-assignment-contractor.pdf (accessed 23 March 2009).
40. Hoadley et al., "The Role of Beneficiary-Centered Assignment for Medicare Part D," 2007, http://www.medpac.gov/documents/June07-Bene- centered-assignment-contractor.pdf. Ibid.
41. Hoadley et al., "The Role of Beneficiary-Centered Assignment for Medicare Part D," 2007, http://www.medpac.gov/documents/June07-Bene- centered-assignment-contractor.pdf. Ibid.
42. R.G. Frank and J.P. Newhouse, "Should Drug Prices Be Negotiated under Part D of Medicare? And If So, How?" Health Affairs 27, no. 1 (2008): 33-43.
43. R.G. Frank and J.P. Newhouse, "Should Drug Prices Be Negotiated under Part D of Medicare? And If So, How?" Health Affairs 27, no. 1 (2008): 33-43. Ibid.
44. Hoadley et al., "Medicare Part D 2008 Data Spotlight."